# Intensity Therapeutics, Inc.: Form DEF 14A, filed Jun 2, 2025

- Company: [Intensity Therapeutics, Inc.](/companies/ints.md) (CIK 1567264)
- Form: DEF 14A
- Filed: 2025-06-02
- Accepted by EDGAR: Jun 2, 2025, 16:01 ET
- Period: 2025-06-02
- Accession: 0001567264-25-000050
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1567264/000156726425000050/intensity-proxystatement20.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1567264/000156726425000050/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1567264/000156726425000050/intensity-proxystatement20.htm

Filed Jun 2, 2025.
Source: SEC EDGAR, the filing index for accession 0001567264-25-000050. Last ingested by Listed: Nov 5, 2026, 12:12 ET. No prices; not investment advice.
